ST Jiaying: Net loss during the first half of 2026 is expected to be between 11.54 million and 14.1 million yuan.

ST Jiaying announced that it is expected that the net profit attributable to shareholders of the listed company in the first half of 2026 will be between -14107.1 million and -11542.2 million, compared to 2008.26 million in the same period last year, turning from profit to loss. After deducting non-recurring gains and losses, the net profit is expected to be between -16602.9 million and -13584.2 million, compared to 1878.86 million in the same period last year. The main reason for the loss is the decrease in drug sales due to market adjustments, resulting in a decrease in revenue and an increase in expenses.